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there is concordance with postoperative clinical outcomes. 
Dr. Lee's venting method is that used since the dawn of 
cardiac surgery. It has withstood the test of time as being 
an excellent way to rid the left ventricle of significant 
amounts of air. Other techniques may be equally effica- 
cious. 
We thank Dr. Lee for bringing this source of microem- 
bolism into focus for a directed study. 
Richard E. Clark, MD 
Director, Cardiovascular and Pulmonary Research Center 
Allegheny-Singer Research Institute 
Pittsburgh, PA 15212 
12/8/66605 
The scientific development of dynamic 
cardiomyoplasty 
To the Editor: 
The invited letter by Dr. Silverman 1 regarding the 
results of Dr. Moreira's group after 5 years of experience 
with dynamic ardiomyoplasty provided a useful analysis 
of the study and some general comments on cardiomyo- 
plasty. We cannot agree with his statement in the opening 
paragraph that the development of the technique did not 
conform to an idealized scientific progression. On the 
contrary, the evolution of cardiomyoplasty followed an 
unmistakable progression from observation to experimen- 
tal study to clinical application. As early as the 1960s, 
experimental studies attempting to use the mechanical 
power of skeletal muscle to assist he heart are detailed, 
but all faced the problem of muscle fatigue. In the 1970s, 
Salmons and Pette demonstrated, and published in Nature 
and The European Journal of Physiology (Pfluegers Ar- 
chives), that fatiguable fast-twitch muscle fibers could be 
transformed into fatigue-resistant slow-twitch fibers by 
slow-rate electrical stimulation. Further histochemical 
studies demonstrated that the metabolism of the fast- 
twitch muscles changed from glycolytic to oxidative, which 
is characteristic of slow-twitch fibers. This muscle plastic- 
ity resulted from the capacity of genes to code for various 
myosin isoforms. Research was initiated in our laboratory 
in 1980 to investigate the possibility that the same trans- 
formation could be obtained at heart frequency rates and 
that it could remain stable and efficient for many years. 
Using a goat animal model 2and newly developed latissi- 
mus dorsi muscle (LDM) pacing electrodes and an im- 
plantable Cardio-Myostimulator device, 3 we developed 
the surgical technique and the concept of progressive 
LDM training using an original protocol of progressive 
sequential stimulation. 4 It is with this background of 
5 years of animal experimentation in our unit, as well as 
several years of worldwide experimentation a d observa- 
tion, that the first clinical case was performed at Broussais 
Hospital in 1985. Despite having had the posterior wall of 
both ventricles replaced with an LDM flap, that patient 
remains well after 10 years and the flap retains fatigue- 
free contraction. 
Current clinical experience includes 80 cases from our 
institution and 500 cases worldwide. The international 
literature is extensive; three books and more than 100 
articles on basic research ave been published. There is a 
biennial International Meeting on Dynamic Cardiomyo- 
plasty and also an international multicentric study in 
conjunction with surgical centers from 15 countries. Their 
purpose is to evaluate results of both laboratory and 
clinical studies and to institute uniform protocols and 
postoperative schedules. Methods of evaluation continue 
to improve and studies involving left ventricular conduc- 
tance catheters and aortic modelflow methods now dem- 
onstrate improved cardiac function 6 to 24 months after 
cardiomyoplasty. 5 
Dr. Silverman urges participating groups to state that 
cardiomyoplasty may have only limited value. Jatene and 
Moreira 6have previously answered Dr. Silverman on this 
issue, stating that their intention was not to create enthu- 
siasm but to further present data and in the current article 
give reference to several studies on present limitations. In 
early publications Carpentier, 7 Chachques, 8 and their 
associates have repeatedly referred to the questionable 
efficiency and the future of the nascent echnique. Their 
more recent results are more encouraging--7 year's sur- 
vival of 52% and hospital mortality rate of 12% between 
1988 and 1995 (8/66 patients). Survival of patients with 
medical therapy alone in a well-matched population was 
significantly worse. 9
In summary, we do not agree with many of Dr. Silver- 
man's statements regarding cardiomyoplasty. The power 
of contraction of the LDM is impressive, generating four 
times the force of cardiac muscle. The fact that it can 
contract without fatigue for potentially more than 10 years 
is a powerful stimulus for investigation and trials because 
of the shortage of donors for transplantation. Bearing in 
mind that the mean survival of the first 100 heart trans- 
plantations was 29 days, the development of dynamic 
cardiomyoplasty has taken great strides ince its inception, 
both in the development of the biophysical science of 
adaptation of skeletal muscle and in the surgical tech- 
nique. The development of cardiomyoplasty has con- 
formed in the past to a rigorous scientific progression 
from observation to experimentation to patient applica- 
tion, 1° and it continues to conform. 
Juan C. Chachques, MD, PhD 
Alain F. Carpentier, MD, PhD 
Department of Cardiovascular Surgery 
Broussais Hospital 
96 rue Didot 
75014 Paris, France 
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Reply to the Editor: 
It is understandable that Drs. Chachques and Carpen- 
tier take strong issue with my invited letter, given their 
experimental nd clinical experience with skeletal muscle 
assistance. However, the volume of journal verbiage does 
not directly correlate with clinical efficacy. Without ques- 
tion, both experimentally and clinically, skeletal muscle 
fibers can be transformed into fatigue-resistant slow- 
twitch fibers by electrical stimulation. However, anecdotal 
presentation of a case in which a patient has been doing 
well for 10 years after the operation does not replace 
long-term animal studies of improved cardiac perfor- 
mance in heart failure preparations. 
The literature presenting clinical results of direct skele- 
tal myoplasty antedates the majority of experimental work 
on long-term support. The majority of the earlier experi- 
mental work involved construction of auxiliary ventricles 
that provided diastolic counterpulsation a d not direct 
dynamic ardiornyoplasty. Moreover, I stand by my asser- 
tion that tailored aggressive medical therapy stabilizes and 
improves the condition of many patients. Thus survival on 
transplant lists is much improved, so that many patients 
can be removed from the list. 
The clinical exigency of the mid-1990s is to find a 
reliable and effective means of cardiac replacement for 
those individuals whose condition cannot be stabilized 
and who require urgent surgical interverition. A shelf 
item, such as an implantable artificial heart, seems far 
more appropriate than skeletal muscle assistance that 
necessitates conditioning, impedes diastolic function, and 
does not obviate ventricular arrhythmias, which are a 
common mode of death in patients with end-stage con- 
gestive heart failure. 
My comments were not meant to completely debunk 
skeletal muscle assistance. Rather, they were intended to 
strongly state a personal bias that a disproportionate 
amount of time and effort is being channeled toward an 
operation that has not been subjected to controlled stud- 
ies, despite a decade of experience, and conceptually 
cannot be applied to the common clinical circumstance of
medically refractory hemodynamic compromise. 
Norman A. Silverman, MD 
Head, Division of Cardiac and Thoracic Surgery 
Henry Ford Hospital 
Detroit, All 48202-2689 
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Aorta-coronary bypass in patients with coronary 
artery disease who do not have angina: A brief 
follow-up fifteen years after the last case reported* 
That which is most secret is most dangerous. Twenty 
rebellious drums make not so dangerous a noise as a few 
whisperers and secret plotters in corners. The cannon 
does not so much hurt against a wall, as a mine under the 
wall; nor a thousand enemies that threaten, so much as a 
few that take an oath to say nothing. 
X Meditation: Lente et serpenti satagunt occurere 
morbo.t 
Devotions Upon Emergent Occasions, 1624 
John Donne 
To the Editor: 
In 1984 we I reported on 723 consecutive patients 
having a first coronary bypass procedure between Novem- 
ber 1971 and October 1979. Of these patients, 605 (84%) 
had angina within 3 months of study and 118 (16%) did 
not. Our policy z of offering myocardial revascularization 
to individuals with important obstructive coronary athero- 
sclerosis and myocardial ischemia, irrespective of angina, 
dated to the first patient with myocardial ischemia without 
angina. This patient had a Vineberg procedure in October 
1965, one of 160 such myocardial revascularizations done 
by Dr. G. David Hooper in Ottawa. We 3' 4 reported 22 
asymptomatic cases, without operative mortality. Evi- 
dence of myocardial ischemia without angina, even in 
conjunction with abnormal hemodynamic results of exer- 
cise tests, was presented. We stated: "To date the 
Vineberg operation appears to have been reserved for 
*The work from which this study arose was supported in part by 
a grant from the Chief of Research and Development 
(CRAD) of the Department ofNational Defence, which does 
not necessarily agree with the authors' opinions and conclu- 
sions. 
tThey find the disease to steal on insensibly, and endeavor to 
meet with it so. 
